Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Business News Schedule at 1500 GMT/11 AM ET

Thu, 19th Apr 2018 16:23

Editor: Steve Orlofsky +1 646 223 6200

Global Picture Desk: +65 6870 3775

Global Graphics Desk: + 65 6870 3595

(All times GMT / ET)

Receive this schedule by email:

http://mediaexpress.reuters.com

TOP STORIES

Allergan moves in as Shire rebuffs $63 bln Takeda bid-sources

LONDON/NEW YORK - Drugmaker Shire has rejected a thirdtakeover bid worth nearly $63 billion from Japan's TakedaPharmaceutical, although talks are continuing, while sources sayAllergan is also in competing negotiations. (SHIRE-M&A/TAKEDAPHARMA-BID (UPDATE 2), moved, by Greg Roumeliotis, Ben Hirschlerand Ben Martin, 550 words)

EXCLUSIVE-China looks to speed up chip plans as U.S. tradetensions boil -sources

BEIJING - China is looking to accelerate plans to developits domestic semiconductor market amid a fierce trade stand-offwith the United States and a U.S. ban on sales to Chinese phonemaker ZTE that has underscored the country's reliance onimported chips. (USA-TRADE/CHINA-CHIPS (EXCLUSIVE), moved, byElias Glenn and Cate Cadell, 600 words)

P&G to buy German Merck's consumer health unit for $4.2 bln

Procter & Gamble Co will acquire the consumer healthbusiness of Merck KGaA for $4.2 billion, giving it vitaminbrands such as Seven Seas and greater exposure to Latin Americanand Asian markets. (MERCK-M&A/P&G (UPDATE 3, PIX), moved, 450words)

MARKETS

Apple, P&G and chip stocks lead Wall St lower

U.S. stock are lower, pulled down by a broad-based slump intechnology stocks from Apple to chipmakers as well as a tumblein consumer staples such as Procter & Gamble. (USA-STOCKS/(UPDATE 3), updated throughout the day, 420 words)

+ See also:

- GLOBAL-MARKETS/ (WRAPUP 4, PIX), updated throughout theday, 830 words

Oil climbs on Saudi price ambitions and U.S. stocks draw

LONDON - Oil prices keep rising to their highest since late2014 as U.S. crude inventories decline, moving closer tofive-year averages, and after sources tell Reuters that topexporter Saudi Arabia aims to push prices even higher.(GLOBAL-OIL/ (UPDATE 7, PIX), updated throughout the day, 430words)

TRADE/ECONOMY

U.S. weekly jobless claims dip in latest week

WASHINGTON - New applications for U.S. unemployment benefitsfell last week, indicating continued job growth after a slowdownin March. (USA-ECONOMY/UNEMPLOYMENT, moved, 340 words)

China says ready to deal with any fallout from U.S. traderow

BEIJING - China is well prepared to handle any negativeeffects from its trade dispute with the United States, thecommerce ministry says, adding that Beijing's tariff hikes onU.S. imports will not have a big impact overall on its domesticindustries. (USA-TRADE/CHINA (WRAPUP 1, TV), moved, by YawenChen and Se Young Lee, 490 words)

Trump, Japan's Abe agree to intensify trade talks

PALM BEACH - U.S. President Donald Trump and Japanese PrimeMinister Shinzo Abe say they have agreed to intensify tradeconsultations between the two longtime allies, with an aim toexpand investment and trade between their countries.(USA-JAPAN/TRADE-IMBALANCES (UPDATE 3), moved, by Steve Holland,500 words)

COMPANIES

As Bon-Ton liquidates, U.S. department stores vie for itsshoppers

With the disappearance of Bon-Ton, which won courtpermission on Wednesday to liquidate, rivals such as Macy's Inc,J.C. Penney Co Inc and Kohls Corp will compete to keep longtimecustomers from turning to discounters like Walmart Inc or onlinejuggernaut Amazon.com Inc. (BON TON STORES-BANKRUPTCY/ (REPEAT),moved, by Tracy Rucinski and Melissa Fares, 480 words)

Nucor profit beats estimates on higher prices, shipments

Nucor Corp reported a higher-than-expected quarterly profitas its shipments and selling price increased, and the company,the No. 1 U.S. steelmaker by market value, forecast asignificant increase in second-quarter profit on a sequentialbasis. (NUCOR-RESULTS/ (UPDATE 1), moved, 210 words)

Market swings knock Blackstone earnings less than feared

Blackstone Group LP, the largest manager of alternativeassets such as private equity and real estate, on Thursdayreported a 20 percent drop in first-quarter earnings per sharebut still beat Wall Street's expectations, as a stock marketslump weighed on the value of its holdings. (BLACKSTONEGROUP-RESULTS/ (UPDATE 1), moved, by Joshua Franklin, 360 words)

China's ZTE removed chief compliance officer before U.S.sanction -source

HONG KONG - ZTE Corp's chief compliance and chief legalofficer was removed from his posts more than a month before theChinese telecom equipment maker was slapped with U.S. sanctionsthis week, a company source with direct knowledge of thesituation told Reuters. (USA-CHINA/ZTE (PIX), moved, by SijiaJiang, 370 words)

+ See also:

- USA-CHINA/ZTE-RIVALS, moved, by Olof Swahnberg and EricAuchard, 770 words

EXCLUSIVE-Facebook to put 1.5 billion users out of reach ofnew EU privacy law

SAN FRANCISCO - If a new European law restricting whatcompanies can do with people's online data went into effecttomorrow, almost 1.9 billion Facebook Inc users around the worldwould be protected by it. The online social network is makingchanges that ensure the number will be much smaller.(FACEBOOK-PRIVACY/EU (UPDATE 1, EXCLUSIVE, PIX), moved, by DavidIngram, 750 words)

Novartis CEO feels heat on U.S. generics, Cosentyx drop

ZURICH - Swiss drugmaker Novartis' first quarterly resultsunder new Chief Executive Vas Narasimhan have been marred by aprized psoriasis treatment that disappointed and a sharp slumpin sales by its U.S. generics unit. (NOVARTIS-RESULTS/ (UPDATE4, PIX), moved, by John Miller, 610 words)

More News
8 May 2018 11:03

WORLD NEWS SCHEDULE AT 1000 GMT/6 AM ET

Editor: Angus MacSwan + 44 207 542 7923 Picture Desk: Singapore + 65 6870 3775 Graphics queries: + 65 6870 3595 (All times GMT) TOP STORIES Trump to reveal Iran

Read more
8 May 2018 09:30

Reuters Business News Schedule at 0830 GMT/430AM ET

Editor: Keith Weir, +44 20 7542 8022 Global Picture Desk: +65 6870 3775 Global Graphics Desk: + 65 6870 3595 (All times GMT / ET) Receive this schedule by Takeda $62 to

Read more
8 May 2018 08:06

Nikkei rises as banks rally; Takeda up ahead of acquisition news

By Ayai Tomisawa TOKYO, May 8 (Reuters) - Japan's Nikkei share average rose on Tuesday as banking stocks rallied while Takeda Pharmaceutical climbed ahead of news the drugmaker had to 4

Read more
8 May 2018 07:59

TOP NEWS: Shire Agrees GBP46 Billion Takeover Deal With Takeda

LONDON (Alliance News) - Irish pharmaceutical company Shire PLC on Tuesday said it has agreed a takeover deal with Japanese peer Takeda Pharmaceutical Co.Takeda is to pay USD30.33 in cash a

Read more
8 May 2018 07:47

LONDON MARKET PRE-OPEN: Lower Call; Shire Agrees Takeda Deal

LONDON (Alliance News) - Stock prices in London are seen opening lower on Tuesday ahead of US President Donald Trump's decision on whether to scrap the nuclear deal with Iran, while in London

Read more
8 May 2018 07:44

UPDATE 1-Japan's Takeda agrees $62 billion takeover of Shire

LONDON, May 8 (Reuters) - Takeda Pharma agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) on Tuesday after the Japanese company raised the amount of cash in its offer to a

Read more
8 May 2018 07:18

Japan's Takeda agrees $62 billion takeover of Shire

LONDON, May 8 (Reuters) - Takeda Pharma agreed to buy London-listed Shire for 46 billion pounds ($62.42 billion) on Tuesday after the Japenese company raised the amount of cash in its offer to to

Read more
8 May 2018 06:25

UK Stocks-Factors to watch on May 8

May 8 (Reuters) - Britain's FTSE 100 index is seen opening 13 points higher at 7,580 on Tuesday, according to financial bookmakers. * VIRGIN MONEY: Virgin Money said on Monday it had received an

Read more
8 May 2018 03:31

Nikkei rises, helped by tech stocks, banks, Takeda's Shire offer

By Ayai Tomisawa TOKYO, May 8 (Reuters) - Japan's Nikkei share average rose on Tuesday as tech shares rallied and Takeda Pharmaceutical jumped after a report the drugmaker will make a 2

Read more
3 May 2018 14:49

Vodafone closes in on game-changing Liberty Global deal

By Ben Martin and Paul Sandle LONDON, May 3 (Reuters) - Vodafone is nearing a transformational deal to buy continental European assets from cable giant Liberty Global and could announce an

Read more
30 Apr 2018 05:05

FOREX-Dollar below 3-month highs as U.S. 10-year yield pulls back

* Dollar index down from Friday's 3-1/2 month peak * Pullback in U.S. 10-year yield dents dollar's momentum * Dollar/yen on track for biggest monthly gain since 2016 *

Read more
27 Apr 2018 05:24

FOREX-Dollar at 3-1/2-month high on elevated yields, euro soft after ECB

* Dollar helped by higher yields; lack of trade, geopolitical news * Euro loses steam after Draghi sounds cautious on economy * Yen capped, sterling helped by Takeda's bid to buy

Read more
27 Apr 2018 02:04

FOREX-Dollar at 3-1/2-month high on elevated yields, euro soft after ECB

* Dollar helped by higher yields; lack of trade, geopolitical news * Euro loses steam after Draghi sounds cautious on economy * Yen capped, sterling helped by Takeda's bid to buy

Read more
26 Apr 2018 16:17

EXTRA: Bid-Target Shire's Stellar First-Quarter Performance Overlooked

LONDON (Alliance News) - Shire PLC delivered a strong first-quarter performance, but the report was overshadowed by the protracted takeover approach by Japan's Takeda Pharmaceutical Co, to the

Read more
26 Apr 2018 12:45

UPDATE 1-Bid target Shire grows earnings 6 pct, holds cautious outlook

LONDON, April 26 (Reuters) - Shire, the London-listed drugmaker targeted by Takeda Pharmaceutical , reported a 6 percent rise in first-quarter earnings on Thursday, while keeping its cautious for

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.